Global Recombinant Human Coagulation VIIa Competitive Landscape Professional Research Report 2025

Global Recombinant Human Coagulation VIIa Competitive Landscape Professional Research Report 2025



Research Summary

Recombinant Human Coagulation VIIa (rFVIIa) is a synthetic form of human activated factor VII, a protein essential for blood clotting. It is produced using recombinant DNA technology, allowing for the creation of a biologically active version of the clotting factor. rFVIIa is used in medical settings, particularly in hemophilia management. Individuals with hemophilia, a genetic disorder characterized by deficient or defective clotting factors, may receive rFVIIa as a therapeutic intervention to promote blood clotting and prevent excessive bleeding. Additionally, rFVIIa has been explored for its hemostatic effects in various clinical scenarios, including surgical procedures and trauma situations where conventional treatments may be insufficient. The recombinant form provides a safe and effective alternative to plasma-derived coagulation factors, reducing the risk of viral transmission and other complications associated with traditional blood products.

According to DIResearch's in-depth investigation and research, the global Recombinant Human Coagulation VIIa market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Recombinant Human Coagulation VIIa include Novo Nordisk, LFB SA HEMA Biologics, AryoGen Pharmed, GENERIUM etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Recombinant Human Coagulation VIIa. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Recombinant Human Coagulation VIIa market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Recombinant Human Coagulation VIIa market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Recombinant Human Coagulation VIIa industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Recombinant Human Coagulation VIIa Include:

Novo Nordisk

LFB SA HEMA Biologics

AryoGen Pharmed

GENERIUM

Recombinant Human Coagulation VIIa Product Segment Include:

1 mg

2 mg

5 mg

8 mg

Recombinant Human Coagulation VIIa Product Application Include:

Congenital Hemophilia

Acquired Hemophilia

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Recombinant Human Coagulation VIIa Industry PESTEL Analysis

Chapter 3: Global Recombinant Human Coagulation VIIa Industry Porter’s Five Forces Analysis

Chapter 4: Global Recombinant Human Coagulation VIIa Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Recombinant Human Coagulation VIIa Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Recombinant Human Coagulation VIIa Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Recombinant Human Coagulation VIIa Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Recombinant Human Coagulation VIIa Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Recombinant Human Coagulation VIIa Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Recombinant Human Coagulation VIIa Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Recombinant Human Coagulation VIIa Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Recombinant Human Coagulation VIIa Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Recombinant Human Coagulation VIIa Market Overview
1.1 Product Definition and Statistical Scope
1.2 Recombinant Human Coagulation VIIa Product by Type
1.2.1 1 mg
1.2.2 2 mg
1.2.3 5 mg
1.2.4 8 mg
1.3 Recombinant Human Coagulation VIIa Product by Application
1.3.1 Congenital Hemophilia
1.3.2 Acquired Hemophilia
1.4 Global Recombinant Human Coagulation VIIa Market Revenue and Sales Analysis
1.4.1 Global Recombinant Human Coagulation VIIa Revenue Market Size Analysis (2020-2032)
1.4.2 Global Recombinant Human Coagulation VIIa Sales Market Size Analysis (2020-2032)
1.4.3 Global Recombinant Human Coagulation VIIa Market Sales Price Trend Analysis (2020-2032)
1.5 Recombinant Human Coagulation VIIa Industry Trends and Innovation
1.5.1 Recombinant Human Coagulation VIIa Industry Trends and Innovation
1.5.2 Recombinant Human Coagulation VIIa Market Drivers and Challenges
2 Recombinant Human Coagulation VIIa Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Recombinant Human Coagulation VIIa Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Recombinant Human Coagulation VIIa Market Analysis by Regions
4.1 Recombinant Human Coagulation VIIa Overall Market: 2024 VS 2025 VS 2032
4.2 Global Recombinant Human Coagulation VIIa Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Recombinant Human Coagulation VIIa Revenue and Market Share by Region (2020-2025)
4.2.2 Global Recombinant Human Coagulation VIIa Revenue and Market Share Forecast by Region (2026-2032)
4.3 Global Recombinant Human Coagulation VIIa Sales and Forecast Analysis (2020-2032)
4.3.1 Global Recombinant Human Coagulation VIIa Sales and Market Share by Region (2020-2025)
4.3.2 Global Recombinant Human Coagulation VIIa Sales Forecast by Region (2026-2032)
4.4 Global Recombinant Human Coagulation VIIa Sales Price Trend Analysis (2020-2032)
5 Global Recombinant Human Coagulation VIIa Market Size by Type and Application
5.1 Global Recombinant Human Coagulation VIIa Market Size by Type
5.1.1 Global Recombinant Human Coagulation VIIa Revenue and Forecast Analysis by Type (2020-2032)
5.1.2 Global Recombinant Human Coagulation VIIa Sales and Forecast Analysis by Type (2020-2032)
5.2 Global Recombinant Human Coagulation VIIa Market Size by Application
5.2.1 Global Recombinant Human Coagulation VIIa Revenue and Forecast Analysis by Application (2020-2032)
5.2.2 Global Recombinant Human Coagulation VIIa Sales and Forecast Analysis by Application (2020-2032)
6 North America
6.1 North America Recombinant Human Coagulation VIIa Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Manufacturers Analysis
6.3 North America Recombinant Human Coagulation VIIa Market Size by Type
6.3.1 North America Recombinant Human Coagulation VIIa Sales by Type (2020-2032)
6.3.2 North America Recombinant Human Coagulation VIIa Revenue by Type (2020-2032)
6.4 North America Recombinant Human Coagulation VIIa Market Size by Application
6.4.1 North America Recombinant Human Coagulation VIIa Sales by Application (2020-2032)
6.4.2 North America Recombinant Human Coagulation VIIa Revenue by Application (2020-2032)
6.5 North America Recombinant Human Coagulation VIIa Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Recombinant Human Coagulation VIIa Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Recombinant Human Coagulation VIIa Market Size by Type
7.3.1 Europe Recombinant Human Coagulation VIIa Sales by Type (2020-2032)
7.3.2 Europe Recombinant Human Coagulation VIIa Revenue by Type (2020-2032)
7.4 Europe Recombinant Human Coagulation VIIa Market Size by Application
7.4.1 Europe Recombinant Human Coagulation VIIa Sales by Application (2020-2032)
7.4.2 Europe Recombinant Human Coagulation VIIa Revenue by Application (2020-2032)
7.5 Europe Recombinant Human Coagulation VIIa Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Recombinant Human Coagulation VIIa Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Manufacturers Analysis
8.3 China Recombinant Human Coagulation VIIa Market Size by Type
8.3.1 China Recombinant Human Coagulation VIIa Sales by Type (2020-2032)
8.3.2 China Recombinant Human Coagulation VIIa Revenue by Type (2020-2032)
8.4 China Recombinant Human Coagulation VIIa Market Size by Application
8.4.1 China Recombinant Human Coagulation VIIa Sales by Application (2020-2032)
8.4.2 China Recombinant Human Coagulation VIIa Revenue by Application (2020-2032)
9 APAC (excl. China)
9.1 APAC (excl. China) Recombinant Human Coagulation VIIa Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Recombinant Human Coagulation VIIa Market Size by Type
9.3.1 APAC (excl. China) Recombinant Human Coagulation VIIa Sales by Type (2020-2032)
9.3.2 APAC (excl. China) Recombinant Human Coagulation VIIa Revenue by Type (2020-2032)
9.4 APAC (excl. China) Recombinant Human Coagulation VIIa Market Size by Application
9.4.1 APAC (excl. China) Recombinant Human Coagulation VIIa Sales by Application (2020-2032)
9.4.2 APAC (excl. China) Recombinant Human Coagulation VIIa Revenue by Application (2020-2032)
9.5 APAC (excl. China) Recombinant Human Coagulation VIIa Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 Latin America
10.1 Latin America Recombinant Human Coagulation VIIa Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Recombinant Human Coagulation VIIa Market Size by Type
10.3.1 Latin America Recombinant Human Coagulation VIIa Sales by Type (2020-2032)
10.3.2 Latin America Recombinant Human Coagulation VIIa Revenue by Type (2020-2032)
10.4 Latin America Recombinant Human Coagulation VIIa Market Size by Application
10.4.1 Latin America Recombinant Human Coagulation VIIa Sales by Application (2020-2032)
10.4.2 Latin America Recombinant Human Coagulation VIIa Revenue by Application (2020-2032)
10.5 Latin America Recombinant Human Coagulation VIIa Market Size by Country
10.6 Latin America Recombinant Human Coagulation VIIa Market Size by Country
10.6.1 Mexico
10.6.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Recombinant Human Coagulation VIIa Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Recombinant Human Coagulation VIIa Market Size by Type
11.3.1 Middle East & Africa Recombinant Human Coagulation VIIa Sales by Type (2020-2032)
11.3.2 Middle East & Africa Recombinant Human Coagulation VIIa Revenue by Type (2020-2032)
11.4 Middle East & Africa Recombinant Human Coagulation VIIa Market Size by Application
11.4.1 Middle East & Africa Recombinant Human Coagulation VIIa Sales by Application (2020-2032)
11.4.2 Middle East & Africa Recombinant Human Coagulation VIIa Revenue by Application (2020-2032)
11.5 Middle East Recombinant Human Coagulation VIIa Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Recombinant Human Coagulation VIIa Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
12.1.1 Global Recombinant Human Coagulation VIIa Market Sales by Key Manufacturers (2021-2025)
12.1.2 Global Recombinant Human Coagulation VIIa Market Revenue by Key Manufacturers (2021-2025)
12.1.3 Global Recombinant Human Coagulation VIIa Average Sales Price by Manufacturers (2021-2025)
12.2 Recombinant Human Coagulation VIIa Competitive Landscape Analysis and Market Dynamic
12.2.1 Recombinant Human Coagulation VIIa Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Novo Nordisk Recombinant Human Coagulation VIIa Product Portfolio
13.1.3 Novo Nordisk Recombinant Human Coagulation VIIa Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.2 LFB SA HEMA Biologics
13.2.1 LFB SA HEMA Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Product Portfolio
13.2.3 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.3 AryoGen Pharmed
13.3.1 AryoGen Pharmed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 AryoGen Pharmed Recombinant Human Coagulation VIIa Product Portfolio
13.3.3 AryoGen Pharmed Recombinant Human Coagulation VIIa Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.4 GENERIUM
13.4.1 GENERIUM Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 GENERIUM Recombinant Human Coagulation VIIa Product Portfolio
13.4.3 GENERIUM Recombinant Human Coagulation VIIa Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis
14.1 Recombinant Human Coagulation VIIa Industry Chain Analysis
14.2 Recombinant Human Coagulation VIIa Industry Raw Material and Suppliers Analysis
14.2.1 Recombinant Human Coagulation VIIa Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Recombinant Human Coagulation VIIa Typical Downstream Customers
14.4 Recombinant Human Coagulation VIIa Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Loading...

In this report,

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings